Skip Navigation



Nucleic Acids Research Advance Access published online on December 14, 2006

Nucleic Acids Research, doi:10.1093/nar/gkl1084
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (1325K) Freely available
Right arrow Screen PDF (365K) Freely available
Right arrowOA All Versions of this Article:
35/2/550    most recent
gkl1084v2
gkl1084v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Zhao, X.
Right arrow Articles by Yu, Y.-T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, X.
Right arrow Articles by Yu, Y.-T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 The Author(s).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


RNA

Incorporation of 5-fluorouracil into U2 snRNA blocks pseudouridylation and pre-mRNA splicing in vivo

Xinliang Zhao and Yi-Tao Yu*

Department of Biochemistry and Biophysics, University of Rochester Medical Center 601 Elmwood Avenue, Rochester, NY 14642, USA

*To whom correspondence should be addressed. Tel: +1 585 275 1271; Fax: +1 585 275 6007; Email: yitao_yu{at}urmc.rochester.edu

Received September 19, 2006. Revised November 24, 2006. Accepted November 27, 2006.

5-fluorouracil (5FU) is an effective anti-cancer drug, yet its mechanism of action remains unclear. Here, we examine the effect of 5FU on pre-mRNA splicing in vivo. Using RT–PCR, we show that the splicing of a number of pre-mRNAs is inhibited in HeLa cells that have been exposed to a low dose of 5FU. It appears that this inhibitory effect is not due to its incorporation into pre-mRNA, because partially or fully 5FU-substituted pre-mRNA, when injected into Xenopus oocytes, is spliced just as well as is the unsubstituted pre-mRNA. Detailed analyses of 5FU-treated cells indicate that 5FU is incorporated into U2 snRNA at important naturally occurring pseudouridylation sites. Remarkably, 5FU incorporation effectively blocks the formation of important pseudouridines in U2 snRNA, as only a trace of pseudouridine is detected when cells are exposed to a low dose of 5FU for 5 days. Injection of the hypopseudouridylated HeLa U2 snRNA into U2-depleted Xenopus oocytes fails to reconstitute pre-mRNA splicing, whereas control U2 isolated from untreated or uracil-treated HeLa cells completely reconstitutes the splicing. Our results demonstrate for the first time that 5FU incorporates into a spliceosomal snRNA at natural pseudouridylation sites in vivo, thereby inhibiting snRNA pseudouridylation and splicing. This mechanism may contribute substantially to 5FU-mediated cell death.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
RNAHome page
M. Xiao, C. Yang, P. Schattner, and Y.-T. Yu
Functionality and substrate specificity of human box H/ACA guide RNAs
RNA, January 1, 2009; 15(1): 176 - 186.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
J. Hoskins and J. S. Butler
RNA-Based 5-Fluorouracil Toxicity Requires the Pseudouridylation Activity of Cbf5p
Genetics, May 1, 2008; 179(1): 323 - 330.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
M. Gustavsson and H. Ronne
Evidence that tRNA modifying enzymes are important in vivo targets for 5-fluorouracil in yeast
RNA, April 1, 2008; 14(4): 666 - 674.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.